Structural basis for the neurotropic AAV9 and the engineered AAVPHP.eB recognition with cellular receptors
Clade F adeno-associated virus (AAV) 9 has been utilized as therapeutic gene delivery vector, and it is capable of crossing blood brain barrier (BBB). Recently, an AAV9-based engineering serotype AAVPHP.eB with enhanced BBB crossing ability further expanded clade F AAVs’ usages in the murine central...
Main Authors: | Guangxue Xu, Ran Zhang, Huapeng Li, Kaixin Yin, Xinyi Ma, Zhiyong Lou |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-09-01
|
Series: | Molecular Therapy: Methods & Clinical Development |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050122000742 |
Similar Items
-
Structural basis of receptor usage by the engineered capsid AAV-PHP.eB
by: Seongmin Jang, et al.
Published: (2022-09-01) -
The Structure of an AAV5-AAVR Complex at 2.5 Å Resolution: Implications for Cellular Entry and Immune Neutralization of AAV Gene Therapy Vectors
by: Mark A. Silveria, et al.
Published: (2020-11-01) -
Engineering a highly durable adeno-associated virus receptor for analytical applications
by: Kouhei Yoshida, et al.
Published: (2023-12-01) -
Enhanced sensitivity of neutralizing antibody detection for different AAV serotypes using HeLa cells with overexpressed AAVR
by: Zhaoyue Zheng, et al.
Published: (2023-04-01) -
Completion of the AAV Structural Atlas: Serotype Capsid Structures Reveals Clade-Specific Features
by: Mario Mietzsch, et al.
Published: (2021-01-01)